Target intelligence / Profile preview

Microbial cell membrane and biofilm

Molecular classification
Other
01

Overview

Microbial cell membranes and biofilms are not a single molecular target but refer to structural and functional assemblies produced by microorganisms. The microbial cell membrane is a lipid bilayer with embedded proteins that controls the passage of molecules and interacts with the external environment. A biofilm is a structured community of microbial cells encased within a self-produced extracellular polymeric substance (EPS) matrix adhered to biotic or abiotic surfaces. Biofilm formation involves initial adhesion, microcolony formation, maturation, and eventual dispersion of cells[1][2][3][5]. The EPS matrix contains polysaccharides, proteins (such as enzymes and fimbriae), extracellular DNA and lipids, providing cohesion, protection, and a medium for cell–cell communication and horizontal gene transfer[1][2][3][4]. Biofilms protect microorganisms from host immune responses, dehydration, oxidizing agents, and antimicrobial drugs, making infections notoriously difficult to treat and leading to chronic diseases and medical device failures[1][2][5][6]. Drugs targeting biofilms often work by disrupting the matrix, inhibiting EPS synthesis or communication pathways essential for biofilm integrity. The term is broad, referring to a microbial community attribute, not a precise protein, receptor, or enzyme, which lowers its specificity as a molecular therapeutic target.

Other names
Microbial membraneBacterial membraneMicrobial biofilmBacterial biofilm
02

Mechanism of action

Disruption of biofilm matrix (enzymatic degradation, chelation); Increased membrane permeability or disruption; Inhibition of extracellular polymeric substance (EPS) synthesis; Inhibition of cell–cell communication (quorum sensing inhibitors)

03

Biological functions

Cell adhesionBarrier functionSignal transductionNutrient uptakeImmune evasionHorizontal gene transferCell–cell communication
04

Disease associations

InfectionAntibiotic resistanceChronic inflammationMedical device-associated infection
05

Safety considerations

High resistance to conventional antibioticsDifficulty in eradicating chronic infectionsDevice-associated infection recurrenceEnhanced immune evasion leading to persistent infections
06

Interacting drugs

Antibiotics (e.g., penicillins, vancomycin)

2 more in the full profile.

07

Biomarkers

Extracellular DNA (eDNA)Polysaccharides (e.g., Psl, Pel, alginate in Pseudomonas)Fimbriae/pili proteinsCyclic-di-GMP (c-di-GMP) levels

Beyond the preview

Go deeper on Microbial cell membrane and biofilm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell membrane and biofilm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call